The Latest in Follicular Lymphoma

Biosimilar rituximab approved in Europe

June 20, 2017

Follicular Lymphoma

BLA for CAR T-cell therapy granted priority review

May 29, 2017

Follicular Lymphoma

FDA grants priority review to NDA for copanlisib

May 18, 2017

Follicular Lymphoma

Subcutaneous rituximab safe, effective for follicular lymphoma

May 9, 2017

Follicular Lymphoma

Drug receives fast track designation for follicular lymphoma

April 26, 2017

Follicular Lymphoma

In mantle cell lymphoma, triple therapy proves too toxic

April 24, 2017

CHMP recommends approval for rituximab biosimilar

April 23, 2017

Follicular Lymphoma

Thousands expected to get CAR T-cells by 2018

April 20, 2017

Follicular Lymphoma

Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy

April 18, 2017

Follicular Lymphoma

Inhibitor exhibits activity against hematologic malignancies

April 18, 2017

Follicular Lymphoma

Reduced-intensity conditioning may not preserve fertility in young girls after bone marrow transplant

April 17, 2017

Follicular Lymphoma

MAGNIFY in relapsed/refractory mantle cell lymphoma

April 7, 2017

Inhibitor produces durable responses in rel/ref iNHL

April 5, 2017

Follicular Lymphoma

Half of patients retain response to CAR T-cell therapy

April 4, 2017

Follicular Lymphoma

Demystifying the diagnosis and classification of lymphoma: a guide to the hematopathologist’s galaxy

April 1, 2017

Follicular Lymphoma